-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on HCA Healthcare, Raises Price Target to $416

Benzinga·06/02/2025 14:21:12
Listen to the news
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $366 to $416.